They also demonstrated that both genetic and pharmacological inhibitions of GRP94 in human hepatocellular carcinoma cells perturbed multiple growth signals and attenuated their proliferation and expansion. The gene discussed is HSP90B1; the disease is hepatocellular carcinoma.